nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentagastrin—Goserelin—LHCGR—polycystic ovary syndrome	0.0594	1	CrCbGaD
Pentagastrin—CCKBR—Peptide GPCRs—LHCGR—polycystic ovary syndrome	0.0346	0.0368	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Other—ADRA1D—polycystic ovary syndrome	0.0266	0.0283	CbGpPWpGaD
Pentagastrin—CCKBR—Peptide GPCRs—FSHR—polycystic ovary syndrome	0.0253	0.0269	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Other—FSHR—polycystic ovary syndrome	0.0215	0.0228	CbGpPWpGaD
Pentagastrin—CCKBR—Peptide ligand-binding receptors—NPB—polycystic ovary syndrome	0.0195	0.0207	CbGpPWpGaD
Pentagastrin—CCKBR—G alpha (q) signalling events—PTAFR—polycystic ovary syndrome	0.0154	0.0164	CbGpPWpGaD
Pentagastrin—CCKBR—G alpha (q) signalling events—ADRA1D—polycystic ovary syndrome	0.015	0.0159	CbGpPWpGaD
Pentagastrin—CCKBR—G alpha (q) signalling events—ADRA1B—polycystic ovary syndrome	0.0146	0.0155	CbGpPWpGaD
Pentagastrin—CCKBR—Gastrin-CREB signalling pathway via PKC and MAPK—PTAFR—polycystic ovary syndrome	0.0138	0.0147	CbGpPWpGaD
Pentagastrin—CCKBR—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1D—polycystic ovary syndrome	0.0134	0.0142	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—NPB—polycystic ovary syndrome	0.0131	0.0139	CbGpPWpGaD
Pentagastrin—CCKBR—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1B—polycystic ovary syndrome	0.013	0.0138	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—LHCGR—polycystic ovary syndrome	0.0127	0.0135	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—PTGER3—polycystic ovary syndrome	0.0127	0.0135	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—PTAFR—polycystic ovary syndrome	0.0119	0.0127	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—ADRA1D—polycystic ovary syndrome	0.0116	0.0123	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—ADRA1B—polycystic ovary syndrome	0.0113	0.012	CbGpPWpGaD
Pentagastrin—CCKBR—G alpha (q) signalling events—ADRA1A—polycystic ovary syndrome	0.011	0.0117	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—PTGER3—polycystic ovary syndrome	0.0109	0.0116	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—LHCGR—polycystic ovary syndrome	0.0109	0.0116	CbGpPWpGaD
Pentagastrin—CCKBR—G alpha (q) signalling events—GNRH1—polycystic ovary syndrome	0.0103	0.0109	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—PTAFR—polycystic ovary syndrome	0.0102	0.0109	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Other—ADRB2—polycystic ovary syndrome	0.0102	0.0108	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—NPB—polycystic ovary syndrome	0.00996	0.0106	CbGpPWpGaD
Pentagastrin—BCHE—Synthesis, secretion, and deacylation of Ghrelin—GHRL—polycystic ovary syndrome	0.00994	0.0106	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.00991	0.0105	CbGpPWpGaD
Pentagastrin—CCKBR—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1A—polycystic ovary syndrome	0.00987	0.0105	CbGpPWpGaD
Pentagastrin—BCHE—Peptide hormone metabolism—CGB5—polycystic ovary syndrome	0.00978	0.0104	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.00964	0.0102	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.00932	0.00991	CbGpPWpGaD
Pentagastrin—CCKBR—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—polycystic ovary syndrome	0.00917	0.00975	CbGpPWpGaD
Pentagastrin—BCHE—Glycerophospholipid biosynthesis—LPCAT2—polycystic ovary syndrome	0.0087	0.00925	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.00853	0.00906	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.00831	0.00883	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.00831	0.00883	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.00821	0.00873	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.00799	0.00849	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00777	0.00826	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00755	0.00802	CbGpPWpGaD
Pentagastrin—BCHE—Peptide hormone metabolism—CPB2—polycystic ovary syndrome	0.00741	0.00788	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00734	0.0078	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00731	0.00777	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.00725	0.00771	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00703	0.00748	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.00695	0.00739	CbGpPWpGaD
Pentagastrin—CCKBR—G alpha (q) signalling events—GHRL—polycystic ovary syndrome	0.00693	0.00736	CbGpPWpGaD
Pentagastrin—CCKBR—Peptide ligand-binding receptors—GHRL—polycystic ovary syndrome	0.00684	0.00727	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00679	0.00722	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.00621	0.0066	CbGpPWpGaD
Pentagastrin—CCKBR—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—polycystic ovary syndrome	0.0062	0.00659	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00608	0.00647	CbGpPWpGaD
Pentagastrin—BCHE—Phospholipid metabolism—LPCAT2—polycystic ovary syndrome	0.00607	0.00646	CbGpPWpGaD
Pentagastrin—BCHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—polycystic ovary syndrome	0.00598	0.00636	CbGpPWpGaD
Pentagastrin—BCHE—Glycerophospholipid biosynthesis—PNPLA2—polycystic ovary syndrome	0.00576	0.00613	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00563	0.00598	CbGpPWpGaD
Pentagastrin—BCHE—Peptide hormone metabolism—INHBB—polycystic ovary syndrome	0.00562	0.00597	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00556	0.00591	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00535	0.00569	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00529	0.00563	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00517	0.0055	CbGpPWpGaD
Pentagastrin—BCHE—Synthesis, secretion, and deacylation of Ghrelin—INS—polycystic ovary syndrome	0.00511	0.00543	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00511	0.00543	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00509	0.00541	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00498	0.0053	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00498	0.0053	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00496	0.00527	CbGpPWpGaD
Pentagastrin—BCHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—polycystic ovary syndrome	0.00494	0.00526	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00473	0.00503	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.0047	0.00499	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.0047	0.00499	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00462	0.00491	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00459	0.00488	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00443	0.00471	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00439	0.00467	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00426	0.00453	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00426	0.00453	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00426	0.00453	CbGpPWpGaD
Pentagastrin—BCHE—Peptide hormone metabolism—LHB—polycystic ovary syndrome	0.00416	0.00442	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00415	0.00441	CbGpPWpGaD
Pentagastrin—BCHE—Phospholipid metabolism—PNPLA2—polycystic ovary syndrome	0.00402	0.00428	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00399	0.00424	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00387	0.00412	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.0038	0.00404	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00377	0.00401	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00377	0.004	CbGpPWpGaD
Pentagastrin—CCKBR—Peptide ligand-binding receptors—POMC—polycystic ovary syndrome	0.00353	0.00376	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00349	0.00371	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00345	0.00367	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00344	0.00365	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00343	0.00364	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00314	0.00334	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00312	0.00332	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00303	0.00322	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—NPB—polycystic ovary syndrome	0.00302	0.00321	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00299	0.00318	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00292	0.00311	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00289	0.00307	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00285	0.00304	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.0028	0.00298	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00275	0.00292	CbGpPWpGaD
Pentagastrin—BCHE—Peptide hormone metabolism—GHRL—polycystic ovary syndrome	0.00274	0.00292	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00273	0.0029	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00272	0.00289	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00268	0.00285	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00267	0.00284	CbGpPWpGaD
Pentagastrin—BCHE—Peptide hormone metabolism—ACE—polycystic ovary syndrome	0.00266	0.00283	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00265	0.00282	CbGpPWpGaD
Pentagastrin—BCHE—Peptide hormone metabolism—TCF7L2—polycystic ovary syndrome	0.00255	0.00271	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00254	0.00271	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00252	0.00268	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00252	0.00268	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.00243	0.00258	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.00237	0.00252	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.00236	0.00251	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00229	0.00243	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00223	0.00237	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—INHBB—polycystic ovary syndrome	0.00217	0.00231	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00202	0.00215	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.00197	0.0021	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00196	0.00208	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—CGB5—polycystic ovary syndrome	0.00185	0.00196	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—FSHR—polycystic ovary syndrome	0.00184	0.00196	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—POMC—polycystic ovary syndrome	0.00181	0.00192	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.00179	0.00191	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.00173	0.00184	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—MANEA—polycystic ovary syndrome	0.00169	0.0018	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00169	0.00179	CbGpPWpGaD
Pentagastrin—BCHE—Peptide hormone metabolism—LEP—polycystic ovary syndrome	0.00165	0.00176	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—FST—polycystic ovary syndrome	0.00164	0.00175	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00163	0.00174	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00162	0.00173	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—LHB—polycystic ovary syndrome	0.0016	0.00171	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.00157	0.00167	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00155	0.00164	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00155	0.00164	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00153	0.00162	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.00152	0.00161	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.00152	0.00161	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—SCT—polycystic ovary syndrome	0.0015	0.0016	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00148	0.00158	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.00143	0.00152	CbGpPWpGaD
Pentagastrin—BCHE—Peptide hormone metabolism—POMC—polycystic ovary syndrome	0.00142	0.00151	CbGpPWpGaD
Pentagastrin—BCHE—Peptide hormone metabolism—INS—polycystic ovary syndrome	0.00141	0.0015	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—FGF18—polycystic ovary syndrome	0.00141	0.0015	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—ADAMTS7—polycystic ovary syndrome	0.0014	0.00149	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—CPB2—polycystic ovary syndrome	0.0014	0.00149	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—RBP4—polycystic ovary syndrome	0.0014	0.00149	CbGpPWpGaD
Pentagastrin—CCKBR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.00139	0.00148	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00138	0.00146	CbGpPWpGaD
Pentagastrin—BCHE—Peptide hormone metabolism—IGF1—polycystic ovary syndrome	0.00136	0.00145	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00135	0.00144	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—YAP1—polycystic ovary syndrome	0.0013	0.00139	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.0013	0.00138	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—GAB1—polycystic ovary syndrome	0.00129	0.00137	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—INSR—polycystic ovary syndrome	0.00123	0.00131	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00123	0.00131	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00117	0.00125	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00117	0.00124	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.00117	0.00124	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00115	0.00122	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—PGR—polycystic ovary syndrome	0.00114	0.00121	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—INHBB—polycystic ovary syndrome	0.00106	0.00113	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—GHRL—polycystic ovary syndrome	0.00106	0.00113	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—PLAT—polycystic ovary syndrome	0.00106	0.00113	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—DLG4—polycystic ovary syndrome	0.00103	0.0011	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00102	0.00108	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—ATF1—polycystic ovary syndrome	0.00101	0.00107	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000996	0.00106	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000985	0.00105	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000981	0.00104	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—NMNAT3—polycystic ovary syndrome	0.000952	0.00101	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—RPL37A—polycystic ovary syndrome	0.000951	0.00101	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000932	0.000991	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000926	0.000985	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—PRL—polycystic ovary syndrome	0.000924	0.000982	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000908	0.000965	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000891	0.000947	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000888	0.000944	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000877	0.000932	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—LPCAT2—polycystic ovary syndrome	0.000871	0.000926	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—SUOX—polycystic ovary syndrome	0.000871	0.000926	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.00086	0.000914	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000813	0.000864	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—ISYNA1—polycystic ovary syndrome	0.000809	0.000861	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000791	0.000841	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—LHB—polycystic ovary syndrome	0.000785	0.000834	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000774	0.000823	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—NRG1—polycystic ovary syndrome	0.00076	0.000808	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000739	0.000785	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—IGFBP1—polycystic ovary syndrome	0.000701	0.000746	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000701	0.000745	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—TEAD2—polycystic ovary syndrome	0.000688	0.000732	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—AKR1C2—polycystic ovary syndrome	0.000688	0.000732	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000662	0.000704	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000651	0.000693	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000651	0.000692	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—LEP—polycystic ovary syndrome	0.000637	0.000677	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—LMNA—polycystic ovary syndrome	0.000581	0.000618	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—PNPLA2—polycystic ovary syndrome	0.000577	0.000613	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000568	0.000604	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—POMC—polycystic ovary syndrome	0.000547	0.000582	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—SRD5A1—polycystic ovary syndrome	0.000547	0.000581	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—INS—polycystic ovary syndrome	0.000544	0.000579	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000526	0.00056	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000526	0.000559	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—STAR—polycystic ovary syndrome	0.000522	0.000555	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—GHRL—polycystic ovary syndrome	0.000518	0.000551	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000516	0.000548	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—ACE—polycystic ovary syndrome	0.000502	0.000533	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.0005	0.000532	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	0.000482	0.000512	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—HMMR—polycystic ovary syndrome	0.000465	0.000494	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—HSD3B1—polycystic ovary syndrome	0.000444	0.000472	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000438	0.000466	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000416	0.000442	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—LHB—polycystic ovary syndrome	0.000404	0.00043	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000403	0.000428	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—HSD3B2—polycystic ovary syndrome	0.000395	0.00042	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—AKR1C1—polycystic ovary syndrome	0.000383	0.000407	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—SULT2A1—polycystic ovary syndrome	0.000352	0.000375	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000344	0.000366	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—RRM2—polycystic ovary syndrome	0.000341	0.000363	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—YAP1—polycystic ovary syndrome	0.000329	0.00035	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—NAMPT—polycystic ovary syndrome	0.000316	0.000336	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000314	0.000334	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—CYP11A1—polycystic ovary syndrome	0.000312	0.000332	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—LEP—polycystic ovary syndrome	0.000312	0.000331	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.00031	0.000329	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—AKR1C3—polycystic ovary syndrome	0.000295	0.000313	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—CYP17A1—polycystic ovary syndrome	0.00029	0.000308	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—POMC—polycystic ovary syndrome	0.000268	0.000285	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—INS—polycystic ovary syndrome	0.000266	0.000283	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—IGF1—polycystic ovary syndrome	0.000258	0.000274	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—TH—polycystic ovary syndrome	0.000251	0.000267	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—SLC2A4—polycystic ovary syndrome	0.000244	0.00026	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—IL6—polycystic ovary syndrome	0.000238	0.000253	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—CYP19A1—polycystic ovary syndrome	0.00023	0.000244	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—GNAS—polycystic ovary syndrome	0.000205	0.000218	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—NCOR1—polycystic ovary syndrome	0.000195	0.000208	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—CYP1A1—polycystic ovary syndrome	0.000185	0.000197	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—MTHFR—polycystic ovary syndrome	0.000173	0.000183	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—PPARG—polycystic ovary syndrome	0.00014	0.000149	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—POMC—polycystic ovary syndrome	0.000138	0.000147	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—INS—polycystic ovary syndrome	0.000137	0.000146	CbGpPWpGaD
